REQUEST A DEMO
Total
USD $0.00
Search more companies

Avrio Pharm OOO (Аврио Фарм ООО) (Russia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Avrio Pharm OOO Profile Updated: October 18, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Avrio Pharm OOO (Аврио Фарм ООО) is a company based in Russia, with its head office in Moscow. It operates in the Pharmaceutical Preparation Manufacturing industry. The company was established on July 12, 2010. There are currently 1 (2023) people employed by Avrio Pharm OOO (Аврио Фарм ООО). The latest financial highlights indicate a net sales revenue drop of 1.41% in 2024. Its total assets decreased by 3.44% over the same period. The net profit margin of Avrio Pharm OOO (Аврио Фарм ООО) decreased by 33.63% in 2024.

Headquarters
Leningradskii, 15, 35, 1, Pom. 102
Moscow; Moscow; Postal Code: 125040

Contact Details: Purchase the Avrio Pharm OOO (Аврио Фарм ООО) report to view the information.

Basic Information
Total Employees:
Purchase the Avrio Pharm OOO (Аврио Фарм ООО) report to view the information.
Registered Capital:
Purchase the Avrio Pharm OOO (Аврио Фарм ООО) report to view the information.
Financial Auditors:
Purchase the Avrio Pharm OOO (Аврио Фарм ООО) report to view the information.
Incorporation Date:
July 12, 2010
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Avrio Pharm OOO (Аврио Фарм ООО) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-1.41%
Total operating revenue
-1.41%
Operating profit (EBIT)
-90.72%
Net Profit (Loss) for the Period
-117.97%
Total Assets
-3.44%
Total Equity
-21.52%
Operating Profit Margin (ROS)
-39.63%
Net Profit Margin
-33.63%
Return on Equity (ROE)
7.84%
Debt/Equity
38.12%
Quick Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?